The CRC Blueprint

My scientific approach to my own cancer – shared with you.

Recruiting now

A Study of VET3-TGI in Patients With Solid Tumors

Phase 1 · 60 people · 7 sites in United States · Recruiting now

August 11, 2026
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Phase 1 · 437 people · 8 sites in 3 countries · Recruiting now

August 11, 2026
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Phase 1 · 49 people · 3 sites in United States · Recruiting now

August 11, 2026
Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision

Not phased · randomised · 216 people · 1 site in China · Recruiting now

August 11, 2026
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Phase 1 · 15 people · 7 sites in 2 countries · Recruiting now

August 11, 2026
A Global, Integrated, Personalized, Stage-related, Multimodal Therapeutic Approach for Rectal Adenocarcinoma Based on Organ Sparing and Mininvasivity

Not phased · 200 people · 1 site in Italy · Recruiting now

August 11, 2026
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

Phase 1 · 24 people · 1 site in United States · Recruiting now

August 11, 2026
Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer

Phase 2 · 148 people · 1 site in Norway · Recruiting now

August 11, 2026
CT-95 in Advanced Cancers Associated With Mesothelin Expression

Phase 1 · 70 people · 9 sites in United States · Recruiting now

August 11, 2026
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery

Not phased · 25 people · 1 site in United States · Recruiting now

August 11, 2026